✦ LIBER ✦

118 Early phase II study of biochemical modulation chemotherapy (BCM) using 5-fluorouracil (5-FU) and cisplatin (CDDP) for advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Tanaka, F.; Ohtake, Y.; Yanagihara, K.; Fukuse, T.; Hitomi, S.; Wada, H.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1099 Cisplatin (CDDP), 5-fluorouracil (5

✍ Livartowski, A.; Dierick, A.; Beuzeboc, P.; Paraiso, D.; Pouillart, P. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 159 KB

A phase II study with continuous infusio

✍ Tsuchiya, S.; Minato, K.; Nakano, H.; Fuekl, N.; Hoshino, H.; Takise, A.; Ezawa, 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 138 KB

A phase I-II trial of cisplatin (CDDP),

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Chemotherapy with 5-fluorouracil (5-FU)

✍ Frederick Richards Ii; David J. Perry; Maria Goutsou; Caron Modeas; Elaine Muchm 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 569 KB

A phase-II trial of carboplatin (CBDCA)

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Phase II study of cisplatin (CDDP) and 5

✍ Segawa, Y; Ueoka, H; Kiura, K; Sakae, K; Hiraki, Y; Takigawa, N; Eguchi, K; Hira 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 223 KB